After six years, a gaggle of consultants, and long committee meetings to decide the future of our main street, the results are in. We have discovered what doesn’t work.
When women with breast cancer ask for an FDA-cleared and approved intervention to reduce hair loss caused by chemotherapy, insurers too often call it cosmetic. That double standard is indefensible.